17
Letný bioptický seminár SD-IAP Letný bioptický seminár SD-IAP Senec 21-22.6.2013 Senec 21-22.6.2013 MUDr. Juraj Marcinek, PhD. MUDr. Juraj Marcinek, PhD. Prípad SD-IAP 480 Prípad SD-IAP 480 Ústav patologickej anatómie a Konzultačné centrum Ústav patologickej anatómie a Konzultačné centrum hematopatológie UNM a JLF UK hematopatológie UNM a JLF UK

Letný bioptický seminár SD-IAP Senec 21-22.6.2013

  • Upload
    lalasa

  • View
    63

  • Download
    0

Embed Size (px)

DESCRIPTION

Letný bioptický seminár SD-IAP Senec 21-22.6.2013. MUDr. Juraj Marcinek, PhD. Prípad SD-IAP 480. Ústav patologickej anatómie a Konzultačné centrum hematopatológie UNM a JLF UK. - PowerPoint PPT Presentation

Citation preview

Page 1: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAPLetný bioptický seminár SD-IAPSenec 21-22.6.2013Senec 21-22.6.2013

MUDr. Juraj Marcinek, PhD.MUDr. Juraj Marcinek, PhD.

Prípad SD-IAP 480Prípad SD-IAP 480

Ústav patologickej anatómie a Konzultačné centrum Ústav patologickej anatómie a Konzultačné centrum

hematopatológie UNM a JLF UK hematopatológie UNM a JLF UK

Page 2: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 9 - 10.11.2012. Prípad SD-IAP 480

68 yer old man – Ca capitis pancreatis (cT3 N1 MX)68 yer old man – Ca capitis pancreatis (cT3 N1 MX)

makroskopic finding: vhite tumorous mas of 18mm rising aroud pancreatic duct in themakroskopic finding: vhite tumorous mas of 18mm rising aroud pancreatic duct in the

head of pancreashead of pancreas

under duodenal serosa visible tumorous mass corresponding to LNunder duodenal serosa visible tumorous mass corresponding to LN

Page 3: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

Page 4: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

Page 5: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

Page 6: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

?

Page 7: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

PASPAS PASPAS

PASPAS PAS-KPAS-K

Page 8: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

CK20CK20CK7CK7

CK17CK17 CK19CK19

Page 9: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

CEApCEApCEAmCEAm

trypsinetrypsine chymotrypsinechymotrypsine

Page 10: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

HepPar1HepPar1

villinvillin AFPAFP

CD10CD10

Page 11: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

TTF1TTF1

ΒΒ-catenin-catenin glypican 3glypican 3

SchmorlSchmorl

?hepatoid carcinoma of pancreas with focal ductal differentiation

Page 12: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

hepatoid carcinomas – heterogenous neoplasms with morphologic and phenotypic hepatoid carcinomas – heterogenous neoplasms with morphologic and phenotypic

resemblance to hepatocellular carcinoma (HCC)resemblance to hepatocellular carcinoma (HCC)

- most common arise in stomach (since Ishikura et al. 1985)- most common arise in stomach (since Ishikura et al. 1985)

- less common in ovary, testis, esophagus, duodenum, pancreas, - less common in ovary, testis, esophagus, duodenum, pancreas,

colon, rectum, lung, gallblader, urinary tract, uterus, vaginacolon, rectum, lung, gallblader, urinary tract, uterus, vagina

- morphology: trabecular / pseudoacinar / solid growth pattern- morphology: trabecular / pseudoacinar / solid growth pattern

polygonal cells with abundant cytoplasm polygonal cells with abundant cytoplasm

central vesicular nuclei with prominent nucleolicentral vesicular nuclei with prominent nucleoli

pleomorphic cells, sinusoidal vascularisationpleomorphic cells, sinusoidal vascularisation

intracytoplasmic PAS+ hyalinne globulesintracytoplasmic PAS+ hyalinne globules

occasional bile productionoccasional bile production

- usually at least partial tubular/tubulopapilar - usually at least partial tubular/tubulopapilar

growth patterngrowth pattern

- immunohistochemistry: markers of hepatocellular differetiation:- immunohistochemistry: markers of hepatocellular differetiation:

AFP, HepPar1, polyklonal CEA, CD10, glypican 3, albumin mRNAAFP, HepPar1, polyklonal CEA, CD10, glypican 3, albumin mRNA

- usually not all markers are present- usually not all markers are present

- coexpression of cytokeratins atypical for HCC- coexpression of cytokeratins atypical for HCC

Page 13: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

hepatoid carcinoma of pancreas – rare neoplasmhepatoid carcinoma of pancreas – rare neoplasm

- larges study contains 15 cases (Kai et al., Pathology - larges study contains 15 cases (Kai et al., Pathology

International 2012) International 2012)

- clinically unspecific symptoms- clinically unspecific symptoms

- can have elevated serum AFP (7/15) - can have elevated serum AFP (7/15)

- can differentiate form acinar/ductal/islet cells of - can differentiate form acinar/ductal/islet cells of

pancreaspancreas

- common associated with other cellular carcinoma - common associated with other cellular carcinoma

component (endocrine features 5/15, ductal component (endocrine features 5/15, ductal

carcinoma 3/15, acinar carcinoma 1/15) carcinoma 3/15, acinar carcinoma 1/15)

prognosis – hepatoid carcinomas have generally poor prognosis prognosis – hepatoid carcinomas have generally poor prognosis

- most tumors are aggressive with metastasis at time of diagnosis- most tumors are aggressive with metastasis at time of diagnosis

- mainly hematogenous metastases into liver, vascular permeation (veins)- mainly hematogenous metastases into liver, vascular permeation (veins)

- pancreatic hepatoid carcinomas – variable prognosis depending on stage at - pancreatic hepatoid carcinomas – variable prognosis depending on stage at

the time of diagnosis the time of diagnosis

Page 14: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

differential diagnosis of hepatoid carcinomas from: differential diagnosis of hepatoid carcinomas from:

1. hepatocellular carcinoma with extrahepatic spreading – problematic to impossible1. hepatocellular carcinoma with extrahepatic spreading – problematic to impossible

hepatoid carcinomas - morphologically similar, but often contain variabile amounth hepatoid carcinomas - morphologically similar, but often contain variabile amounth glandular or tubulopapilary adenocarcinomatous componentglandular or tubulopapilary adenocarcinomatous component - immunohistochemical pattern of HCC usually incomplete with - immunohistochemical pattern of HCC usually incomplete with strong coexpression of cytokeratins atypical fo HCC (CK19, strong coexpression of cytokeratins atypical fo HCC (CK19, CK17, CK20)CK17, CK20) - CEAm+ in adenocarcinomatous component- CEAm+ in adenocarcinomatous component - CEAp+ in both components (luminal/canalicular in hepatoid c.)- CEAp+ in both components (luminal/canalicular in hepatoid c.) - most important are clinical informations of liver finding- most important are clinical informations of liver finding - HCC spread into pancreas is a rare (2,7-5,6%) and late finding- HCC spread into pancreas is a rare (2,7-5,6%) and late finding - multiple liver nodules without chronic liver disease associated - multiple liver nodules without chronic liver disease associated with other large large gastrointestinal tumor are prone to be with other large large gastrointestinal tumor are prone to be metastasesmetastases

Page 15: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

differential diagnosis of hepatoid carcinoma of pancreasdifferential diagnosis of hepatoid carcinoma of pancreas

2. acinar cell carcinoma (solid variant)2. acinar cell carcinoma (solid variant)

– – morphologically similar cells, granular PAS+ cytoplasm, uniform, basal oriented nuclei morphologically similar cells, granular PAS+ cytoplasm, uniform, basal oriented nuclei

and „palisading“ of nuclei around vessels, distinct nucleoli and „palisading“ of nuclei around vessels, distinct nucleoli

- absence of dezmoplastic stroma- absence of dezmoplastic stroma

- immunohistochemically: lipase+, trypsin+, chymotripsin+- immunohistochemically: lipase+, trypsin+, chymotripsin+

CK19-, CK7-, CK20-, AFP (10% positive)CK19-, CK7-, CK20-, AFP (10% positive)

Page 16: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Letný bioptický seminár SD-IAP 21 – 22.6.2013. Prípad SD-IAP 480

differential diagnosis of hepatoid carcinoma of pancreasdifferential diagnosis of hepatoid carcinoma of pancreas

3. pancreatoblastoma3. pancreatoblastoma

- mainly in children (1st. decade of live)- mainly in children (1st. decade of live)

- trabecular and solid growth pattern with/without other pancreatic structures- trabecular and solid growth pattern with/without other pancreatic structures

(acinar, ductal, endocrine, stromal)(acinar, ductal, endocrine, stromal)

- presence of atypical squamoid corpusles- presence of atypical squamoid corpusles

- a mesenchymal component with stromal hyalinisation may be present - a mesenchymal component with stromal hyalinisation may be present

- immunohistochemically: lipase+, trypsin+, chymotripsin+, AFP+, HMW-CK+- immunohistochemically: lipase+, trypsin+, chymotripsin+, AFP+, HMW-CK+

Page 17: Letný bioptický seminár SD-IAP Senec 21-22.6.2013

Tlstá, Veľká Fatra, 2.7.2008 pohľad na Ostredok a Ostrú

Ďakujem za pozornosť